Immunovant, Inc. (IMVT)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $103k
- Sep 23 · No plan
- Form 4 sales
- 180
- On record
- Form 144 notices
- 5
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planJul 8 2026
Sold 1,206 shares at $39.55 ($48k)
Van Tuyl Christopher, Chief Legal Officer
No 10b5-1 planSold 0.7% of holdings ($7.1M position)179,391 shares left0.2x usual sizeFiling
- 2 Form 4 saleNo planJul 8 same day
Sold 2,036 shares at $39.55 ($81k)
Gloria Melanie, Chief Operating Officer
No 10b5-1 planSold 0.9% of holdings ($8.9M position)222,357 shares left0.2x usual sizeFiling
- 3 Form 4 saleNo planJul 23 +15 days
Sold 6,798 shares at $38.69 ($263k)
Girao Tiago, Chief Financial Officer
No 10b5-1 planSold 2.7% of holdings ($9.6M position)240,798 shares leftFiling
- 4 Form 4 saleNo planJul 23 same day
Sold 2,857 shares at $38.69 ($111k)
Stout Jay S, Chief Technology Officer
No 10b5-1 planSold 1.4% of holdings ($8.1M position)205,341 shares left1x usual sizeFiling
- 5 Form 4 saleRoutineJul 24 +1 day
Sold 1,500 shares at $39.80 ($60k)
Pande Atul, Director
10b5-1 planSold 1.3% of holdings ($4.7M position)116,731 shares left0.4x usual sizeFiling
- 6 Form 4 saleNo planAug 20 +27 days
Sold 3,056 shares at $44.16 ($135k)
Gloria Melanie, Chief Operating Officer
No 10b5-1 planSold 1.4% of holdings ($9.8M position)219,301 shares left0.5x usual sizeFiling
- 7 Form 4 saleRoutineAug 28 +8 days
Sold 1,500 shares at $43.27 ($65k)
Pande Atul, Director
10b5-1 planSold 1.3% of holdings ($5.1M position)116,731 shares left1x usual sizeFiling
- 8 Form 4 saleNo planSep 23 +26 days
Sold 2,846 shares at $36.36 ($103k)
Van Tuyl Christopher, Chief Legal Officer
No 10b5-1 planSold 1.6% of holdings ($6.5M position)176,545 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (185)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 2,846 | $103k | 1.6% | No plan | SEC |
| Aug 28, 2026 | Pande Atul | Director | Form 4 sale | 1,500 | $65k | 1.3% | Routine | SEC |
| Aug 20, 2026 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 3,056 | $135k | 1.4% | No plan | SEC |
| Jul 24, 2026 | Pande Atul | Director | Form 4 sale | 1,500 | $60k | 1.3% | Routine | SEC |
| Jul 23, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,857 | $111k | 1.4% | No plan | SEC |
| Jul 23, 2026 | Girao Tiago | Chief Financial Officer | Form 4 sale | 6,798 | $263k | 2.7% | No plan | SEC |
| Jul 8, 2026 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 2,036 | $81k | 0.9% | No plan | SEC |
| Jul 8, 2026 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 1,206 | $48k | 0.7% | No plan | SEC |
| Jul 8, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 3,487 | $138k | 1.6% | No plan | SEC |
| Jul 2, 2026 | Venker Eric | Chief Executive Officer | Form 4 sale | 3,092 | $119k | 1.2% | No plan | SEC |
| Jun 26, 2026 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 17,714 | $679k | 7.3% | No plan | SEC |
| Jun 26, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 40,000 | $1.5M | 15.9% | Unusual | SEC |
| Jun 26, 2026 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 17,824 | $683k | 9.0% | Unusual | SEC |
| Jun 26, 2026 | Girao Tiago | Chief Financial Officer | Form 4 sale | 10,000 | $385k | 3.9% | No plan | SEC |
| Jun 26, 2026 | Pande Atul | Director | Form 4 sale | 1,500 | $57k | 1.3% | Routine | SEC |
| Jun 18, 2026 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 2,634 | $93k | 1.4% | No plan | SEC |
| Jun 15, 2026 | Pande Atul | Director | Form 4 sale | 1,500 | $51k | 1.3% | Routine | SEC |
| May 28, 2026 | Fromkin Andrew J. | Director | Form 4 sale | 221,951 | $7.4M | 74.9% | Unusual | SEC |
| May 20, 2026 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 3,115 | $101k | 1.3% | No plan | SEC |
| May 20, 2026 | Pande Atul | Director | Form 4 sale | 6,000 | $192k | 4.9% | Routine | SEC |
| May 1, 2026 | Susman Robert Graham | Director | Form 4 sale | 2,502 | $68k | 6.4% | Routine | SEC |
| Apr 23, 2026 | Girao Tiago | Chief Financial Officer | Form 4 sale | 25,760 | $763k | 9.4% | No plan | SEC |
| Apr 23, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,754 | $82k | 1.1% | No plan | SEC |
| Apr 8, 2026 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 8,722 | $217k | 3.4% | No plan | SEC |
| Apr 8, 2026 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 5,165 | $128k | 2.7% | No plan | SEC |
| Apr 8, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 10,132 | $252k | 3.8% | Unusual | SEC |
| Apr 2, 2026 | Venker Eric | Chief Executive Officer | Form 4 sale | 14,229 | $343k | 42.1% | Unusual | SEC |
| Mar 18, 2026 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 2,877 | $72k | 1.9% | No plan | SEC |
| Feb 25, 2026 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 3,238 | $90k | 1.9% | No plan | SEC |
| Jan 21, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 1,977 | $51k | 1.0% | No plan | SEC |
| Jan 7, 2026 | Stout Jay S | Chief Technology Officer | Form 4 sale | 1,203 | $32k | 0.6% | No plan | SEC |
| Dec 18, 2025 | Van Tuyl Christopher | Chief Legal Officer | Form 4 sale | 10,813 | $291k | 6.7% | No plan | SEC |
| Dec 1, 2025 | Fromkin Andrew J. | Director | Form 4 sale | 22,249 | $517k | 20.6% | Routine | SEC |
| Dec 1, 2025 | Hughes Douglas J. | Director | Form 4 sale | 15,000 | $349k | 11.0% | Routine | SEC |
| Nov 20, 2025 | Gloria Melanie | Chief Operating Officer | Form 4 sale | 12,626 | $298k | 6.8% | No plan | SEC |
| Oct 22, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 2,595 | $49k | 1.2% | No plan | SEC |
| Oct 22, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,520 | $48k | 1.2% | No plan | SEC |
| Oct 8, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 1,272 | $21k | 0.6% | No plan | SEC |
| Oct 8, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 1,585 | $26k | 0.8% | No plan | SEC |
| Jul 23, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,805 | $51k | 1.4% | No plan | SEC |
| Jul 23, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 2,385 | $43k | 1.1% | No plan | SEC |
| Jul 9, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 1,160 | $20k | 0.5% | No plan | SEC |
| Jul 9, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 1,519 | $26k | 0.7% | No plan | SEC |
| Apr 23, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 1,925 | $28k | 0.9% | No plan | SEC |
| Apr 23, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 2,349 | $35k | 1.0% | No plan | SEC |
| Apr 16, 2025 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 2,993 | $45k | 0.7% | No plan | SEC |
| Apr 16, 2025 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 8,321 | $124k | 0.7% | No plan | SEC |
| Apr 9, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 5,004 | $65k | 2.3% | No plan | SEC |
| Apr 9, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 6,169 | $80k | 2.6% | No plan | SEC |
| Apr 9, 2025 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 11,063 | $144k | 2.7% | No plan | SEC |
| Apr 9, 2025 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 28,094 | $365k | 2.3% | Unusual | SEC |
| Mar 7, 2025 | Fromkin Andrew J. | Director | Form 4 sale | 8,000 | $157k | 8.0% | Routine | SEC |
| Feb 19, 2025 | Macias William L. | Chief Medical Officer | Form 4 sale | 2,055 | $43k | 0.6% | No plan | SEC |
| Feb 19, 2025 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 2,814 | $59k | 0.9% | No plan | SEC |
| Feb 19, 2025 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 15,439 | $322k | 1.6% | No plan | SEC |
| Jan 22, 2025 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,195 | $52k | 1.5% | No plan | SEC |
| Jan 22, 2025 | Geffner Michael | Chief Medical Officer | Form 4 sale | 2,657 | $63k | 2.0% | No plan | SEC |
| Jan 15, 2025 | Macias William L. | Chief Medical Officer | Form 4 sale | 2,383 | $57k | 0.7% | No plan | SEC |
| Jan 15, 2025 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 2,298 | $55k | 0.7% | No plan | SEC |
| Jan 15, 2025 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 8,767 | $209k | 0.9% | No plan | SEC |
| Jan 8, 2025 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,105 | $99k | 1.2% | No plan | SEC |
| Jan 8, 2025 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 5,105 | $123k | 0.5% | No plan | SEC |
| Dec 2, 2024 | Pande Atul | Director | Form 4 sale | 7,750 | $221k | 8.2% | Routine | SEC |
| Dec 2, 2024 | Hughes Douglas J. | Director | Form 4 sale | 5,425 | $155k | 4.3% | Routine | SEC |
| Dec 2, 2024 | Hughes Douglas J. | Officer | Form 144 notice | 5,425 | $153k | Notice | SEC | |
| Dec 2, 2024 | Pande Atul | Director | Form 144 notice | 7,750 | $219k | Notice | SEC | |
| Nov 20, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,650 | $93k | 1.1% | No plan | SEC |
| Nov 20, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 3,353 | $85k | 0.9% | No plan | SEC |
| Nov 20, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,174 | $106k | 1.2% | No plan | SEC |
| Nov 20, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 16,692 | $425k | 1.7% | No plan | SEC |
| Oct 23, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 4,361 | $129k | 1.3% | No plan | SEC |
| Oct 23, 2024 | Geffner Michael | Chief Medical Officer | Form 4 sale | 3,189 | $94k | 2.3% | No plan | SEC |
| Oct 23, 2024 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,740 | $81k | 1.9% | No plan | SEC |
| Oct 16, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 9,095 | $262k | 0.9% | No plan | SEC |
| Oct 16, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 3,188 | $92k | 0.9% | No plan | SEC |
| Oct 16, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 2,860 | $82k | 0.9% | No plan | SEC |
| Oct 16, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 3,271 | $94k | 1.0% | No plan | SEC |
| Oct 9, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 5,162 | $153k | 1.5% | No plan | SEC |
| Oct 9, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 4,460 | $132k | 0.4% | No plan | SEC |
| Aug 21, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,295 | $105k | 1.0% | No plan | SEC |
| Aug 21, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 3,027 | $96k | 0.8% | No plan | SEC |
| Aug 21, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 3,768 | $120k | 1.1% | No plan | SEC |
| Aug 21, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 3,027 | $96k | 0.7% | No plan | SEC |
| Aug 21, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 15,068 | $480k | 1.5% | No plan | SEC |
| Jul 24, 2024 | Stout Jay S | Chief Technology Officer | Form 4 sale | 2,813 | $78k | 1.9% | No plan | SEC |
| Jul 24, 2024 | Geffner Michael | Chief Medical Officer | Form 4 sale | 3,456 | $96k | 2.4% | No plan | SEC |
| Jul 24, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 4,015 | $111k | 1.2% | No plan | SEC |
| Jul 17, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 2,505 | $74k | 0.7% | No plan | SEC |
| Jul 17, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 3,044 | $90k | 0.8% | Unusual | SEC |
| Jul 17, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 3,123 | $93k | 0.9% | No plan | SEC |
| Jul 17, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 2,867 | $85k | 0.6% | No plan | SEC |
| Jul 17, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 8,685 | $258k | 0.8% | No plan | SEC |
| Jul 9, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,747 | $133k | 1.3% | No plan | SEC |
| Jul 9, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 1,527 | $43k | 0.3% | No plan | SEC |
| Jul 9, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 4,619 | $130k | 0.4% | No plan | SEC |
| May 22, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,042 | $120k | 1.1% | No plan | SEC |
| May 22, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 16,163 | $479k | 1.5% | Unusual | SEC |
| May 22, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 3,247 | $96k | 0.7% | No plan | SEC |
| May 22, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 3,247 | $96k | 0.9% | Unusual | SEC |
| May 22, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,242 | $96k | 0.9% | No plan | SEC |
| Apr 24, 2024 | Geffner Michael | Chief Medical Officer | Form 4 sale | 3,261 | $94k | 2.3% | No plan | SEC |
| Apr 24, 2024 | Stout Jay S | Chief Technology Officer | Form 4 sale | 7,239 | $209k | 4.7% | No plan | SEC |
| Apr 24, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,963 | $115k | 1.1% | No plan | SEC |
| Apr 17, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 9,827 | $286k | 2.8% | No plan | SEC |
| Apr 17, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 8,280 | $241k | 2.1% | Unusual | SEC |
| Apr 17, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 12,253 | $356k | 3.3% | Unusual | SEC |
| Apr 17, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 10,115 | $294k | 2.2% | Unusual | SEC |
| Apr 17, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 34,079 | $990k | 3.1% | Unusual | SEC |
| Apr 9, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 3,689 | $115k | 1.0% | No plan | SEC |
| Apr 9, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 1,053 | $33k | 0.2% | No plan | SEC |
| Apr 9, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 4,807 | $150k | 0.4% | No plan | SEC |
| Feb 22, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 2,930 | $106k | 0.9% | No plan | SEC |
| Feb 22, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 2,134 | $77k | 0.7% | No plan | SEC |
| Feb 22, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 2,221 | $80k | 0.7% | Unusual | SEC |
| Feb 22, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 2,146 | $78k | 0.5% | No plan | SEC |
| Feb 22, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 13,454 | $486k | 1.4% | Unusual | SEC |
| Jan 26, 2024 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,027 | $115k | 1.0% | No plan | SEC |
| Jan 26, 2024 | Geffner Michael | Chief Medical Officer | Form 4 sale | 10,101 | $383k | 10.1% | No plan | SEC |
| Jan 18, 2024 | Macias William L. | Chief Medical Officer | Form 4 sale | 424 | $17k | 0.1% | No plan | SEC |
| Jan 11, 2024 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 3,515 | $147k | 1.1% | No plan | SEC |
| Jan 5, 2024 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 1,297 | $50k | 0.3% | No plan | SEC |
| Jan 5, 2024 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 3,824 | $148k | 0.4% | No plan | SEC |
| Dec 1, 2023 | Fromkin Andrew J. | Director | Form 4 sale | 12,350 | $491k | 12.2% | Routine | SEC |
| Dec 1, 2023 | Pande Atul | Director | Form 4 sale | 12,350 | $491k | 12.9% | Routine | SEC |
| Dec 1, 2023 | Migausky George V | Director | Form 4 sale | 12,700 | $505k | 10.4% | Routine | SEC |
| Dec 1, 2023 | Pande Atul | Director | Form 144 notice | 12,350 | $483k | Notice | SEC | |
| Dec 1, 2023 | Fromkin Andrew J. | Director, Officer | Form 144 notice | 12,350 | $483k | Notice | SEC | |
| Dec 1, 2023 | Migausky George V | Officer | Form 144 notice | 12,700 | $497k | Notice | SEC | |
| Nov 22, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 16,217 | $532k | 1.7% | Unusual | SEC |
| Nov 22, 2023 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,055 | $133k | 1.2% | No plan | SEC |
| Nov 22, 2023 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 3,265 | $107k | 0.8% | No plan | SEC |
| Nov 22, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 3,265 | $107k | 1.0% | Unusual | SEC |
| Nov 22, 2023 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,252 | $107k | 1.0% | No plan | SEC |
| Oct 25, 2023 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 4,107 | $142k | 1.3% | No plan | SEC |
| Oct 19, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 530 | $20k | 0.2% | No plan | SEC |
| Oct 10, 2023 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,557 | $168k | 1.4% | No plan | SEC |
| Oct 5, 2023 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 1,735 | $63k | 0.4% | No plan | SEC |
| Oct 5, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 5,239 | $190k | 0.5% | No plan | SEC |
| Aug 30, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 56,774 | $1.3M | 5.5% | Unusual | SEC |
| Aug 24, 2023 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 12,286 | $249k | 3.8% | Unusual | SEC |
| Aug 24, 2023 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 14,386 | $292k | 4.1% | Unusual | SEC |
| Aug 24, 2023 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 12,333 | $250k | 2.9% | Unusual | SEC |
| Aug 24, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 12,333 | $250k | 3.5% | Unusual | SEC |
| Aug 14, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 103,058 | $2.2M | 9.1% | Unusual | SEC |
| Aug 7, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 101,339 | $2.2M | 8.2% | Unusual | SEC |
| Jul 26, 2023 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 3,917 | $85k | 1.2% | No plan | SEC |
| Jul 19, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 426 | $11k | 0.1% | No plan | SEC |
| Jul 19, 2023 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 2,725 | $68k | 0.8% | No plan | SEC |
| Jul 12, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 3,233 | $64k | 0.3% | No plan | SEC |
| Jul 12, 2023 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 1,470 | $29k | 0.3% | No plan | SEC |
| Apr 25, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 509 | $8k | 0.1% | No plan | SEC |
| Apr 25, 2023 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 2,633 | $43k | 0.8% | No plan | SEC |
| Apr 18, 2023 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 3,423 | $52k | 1.0% | No plan | SEC |
| Apr 18, 2023 | Butchko Julia G. | Chief Development Officer | Form 4 sale | 1,544 | $24k | 0.4% | No plan | SEC |
| Apr 18, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 3,395 | $52k | 0.3% | No plan | SEC |
| Feb 2, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 537 | $10k | 0.2% | Plan not stated | SEC |
| Jan 26, 2023 | Levine Mark S. | Chief Legal Officer | Form 4 sale | 10,156 | $188k | 4.0% | Plan not stated | SEC |
| Jan 11, 2023 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 4,021 | $68k | 0.4% | Plan not stated | SEC |
| Jan 11, 2023 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 60,490 | $1M | 15.4% | Unusual | SEC |
| Jan 11, 2023 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 4,510 | $76k | 1.7% | Plan not stated | SEC |
| Jan 11, 2023 | Macias William L. | Chief Medical Officer | Form 4 sale | 44,568 | $746k | 14.5% | Unusual | SEC |
| Oct 21, 2022 | Macias William L. | Chief Medical Officer | Form 4 sale | 341 | $3k | 0.1% | Plan not stated | SEC |
| Oct 13, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 928 | $9k | 0.2% | Plan not stated | SEC |
| Oct 13, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 2,793 | $26k | 0.3% | Plan not stated | SEC |
| Oct 11, 2022 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 12,500 | $118k | 4.4% | Plan not stated | SEC |
| Sep 28, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 535 | $2k | 0.1% | Plan not stated | SEC |
| Sep 28, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 1,605 | $7k | 0.2% | Plan not stated | SEC |
| Aug 30, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 1,644 | $10k | 0.2% | Plan not stated | SEC |
| Aug 30, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 548 | $3k | 0.1% | Plan not stated | SEC |
| Jul 27, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 510 | $2k | 0.2% | Plan not stated | SEC |
| Jul 27, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 1,528 | $7k | 0.3% | Plan not stated | SEC |
| Jul 22, 2022 | Macias William L. | Chief Medical Officer | Form 4 sale | 322 | $2k | 0.2% | Plan not stated | SEC |
| Jun 29, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 1,376 | $6k | 0.2% | Plan not stated | SEC |
| Jun 29, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 460 | $2k | 0.2% | Plan not stated | SEC |
| May 24, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 492 | $2k | 0.2% | Plan not stated | SEC |
| May 24, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 1,471 | $6k | 0.3% | Plan not stated | SEC |
| Apr 27, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 541 | $3k | 0.2% | Plan not stated | SEC |
| Apr 27, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 1,622 | $8k | 0.3% | Plan not stated | SEC |
| Apr 19, 2022 | Macias William L. | Chief Medical Officer | Form 4 sale | 1,392 | $7k | 0.7% | Plan not stated | SEC |
| Mar 24, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 6,381 | $38k | 2.2% | Plan not stated | SEC |
| Mar 24, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 19,227 | $113k | 3.3% | Plan not stated | SEC |
| Jan 7, 2022 | Butchko Julia G. | Chief Dev. & Tech. Officer | Form 4 sale | 55,318 | $401k | 16.0% | Plan not stated | SEC |
| Jan 7, 2022 | Barnett Eva Renee | Chief Financial Officer | Form 4 sale | 29,959 | $217k | 14.8% | Plan not stated | SEC |
| Jan 7, 2022 | Salzmann Peter | Chief Executive Officer | Form 4 sale | 125,158 | $907k | 17.8% | Plan not stated | SEC |
| Jan 5, 2022 | Macias William L. | Chief Medical Officer | Form 4 sale | 26,813 | $222k | 12.0% | Plan not stated | SEC |